Loading...

Major Indexes

Financial Summary


Apollo Endosurgery Inc.

Apollo Endosurgery Inc. (APEN)

$1.76
0.07 (+4.14%)
Buy
A-
Market Info
Financial Info
Financial Modelling
Symbol APEN
Price 1.76$
Beta 0.99
Volume Avrg. 0.02M
Market Cap 0.04B
Shares (2019) 21,542.28K
Last Div 0
Dividend Yield -
DCF Unlevered -140,614.71 Strong Sell
DCF Levered -138,753.41 Strong Sell
ROE -1292.13% Strong Sell
ROA -36.78% Strong Sell
Operating Margin -46.36% Strong Sell
Debt / Equity 3413.05% Strong Buy
P/E -2.33 Sell
P/B 30.14 Strong Buy

Income Statement

Quarter data
Download APEN income statement Download APEN income statement Download APEN income statement
Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Earnings Per Share Diluted 0.07-0.08-0.05-0.26-0.49-1.00-0.39-105.69-2.01-2.31-1.27
Net Profit Margin 0.33-0.59-0.33-0.41-0.82-3.26-6.26-0.63-0.42-0.75-0.54
Weighted Average Shares Outstanding 54.1855.7762.9713.4021.9221.9221.920.3921.9221.9221.54
Revenue 11,909.277,835.559.396.697.995.081.6064.8764.3160.8550.71
Weighted Average Shares Outstanding (Diluted) 56.8355.7762.9710.7413.4416.5625.730.3913.5719.7921.54
Gross Profit 11,909.277,835.559.396.697.995.081.6039.6139.7333.1925.68
Dividend per Share -----------
Operating Income 1,801.74-4,488.80-3.71-5.56-7.59-17.81-10.86-20.76-22.44-40.09-23.51
Gross Margin 1.001.001.001.001.001.001.000.610.620.550.51
Income Tax Expense -------0.390.300.190.28
EBIT Margin 0.17-0.55-0.38-0.80-0.93-3.46-6.50-0.17-0.19-0.50-0.37
Net Income 3,983.01-4,602.17-3.11-2.75-6.56-16.56-10.01-41.17-27.29-45.79-27.43
Cost of Revenue -------25.2524.5827.6625.04
Earnings Before Tax Margin 0.33-0.59-0.33-0.41-0.82-3.26-6.26-0.63-0.42-0.75-0.54
EBIT 1,801.74-4,488.80-3.71-5.56-7.59-17.81-10.86-20.76-22.44-40.09-23.51
EBITDA 1,978.43-4,323.49-3.57-5.37-7.40-17.59-10.39-11.24-12.42-30.31-18.83
Profit Margin 0.33-0.59-0.33-0.41-0.82-3.26-6.26-0.63-0.42-0.75-0.54
Operating Expenses 14,153.0910,537.3113.1012.2515.5822.8912.4660.3762.1773.2952.70
Earnings Per Share Basic 0.07-0.08-0.05-0.26-0.49-1.00-0.39-105.69-2.01-2.31-1.27
Earnings before Tax 3,983.01-4,602.17-3.11-2.75-6.56-16.56-10.01-40.78-26.99-45.60-27.16
Interest Expense -------18.174.514.064.05

Balance Sheet Statement

Quarter data
Download APEN balance shet statement Download APEN balance sheet statement Download APEN balance sheet statement
Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Short-term debt 15.12------8.51--34.45
Other Assets 1,176.381,478.561,866.172,020.752,215.582,535.412,358.561.471.335.303.85
Total current liabilities 1,893.789,421.7210.078.633.534.261.0820.2825.8324.4552.79
Cash and cash equivalents 6,171.496,803.5114.4124.6211.8517.288.8919.1130.5124.0029.91
Long-term debt 745.851,630.280.110.090.070.04204.246.6333.3221.191.12
Cash and short-term investments 6,171.496,803.5114.4124.6211.8517.288.8919.1130.5124.0029.91
Total debt 15.121,630.280.110.090.070.04204.248.5133.3221.1935.56
Inventories -------12.1614.349.938.87
Deferred revenue 659.576,665.006.085.420.500.13-0.09---
Goodwill and Intangible Assets --1.611.691.932.242.1350.1443.2515.1513.12
Total non-current liabilities 745.851,630.283.642.962.893.493.450.2933.3721.711.75
Total non-current assets --1.872.022.222.542.3658.5051.4626.3523.58
Total liabilities 5,993.7820,831.7217.3112.245.705.141.0859.7159.1545.6472.46
Total assets 7,869.9723,839.0217.9427.1815.6720.9611.61102.12109.0674.4774.58
Other comprehensive income 1,823.172,946.9640.7357.8559.4381.8386.54190.66225.12249.12250.63
Short-term investments -----------
Property, Plant & Equipment Net --0.180.250.210.220.156.896.885.906.61
Net Debt -6,156.37-5,173.23-14.30-24.53-11.78-17.25-8.89-10.612.81-2.815.66
Investments -----------
Total shareholders equity 1,876.203,007.300.6314.949.9715.8210.5342.4249.9128.832.12
Retained earnings (deficit) ---40.16-42.91-49.48-66.03-76.04-149.73-177.02-222.81-250.16
Long-term investments -----------
Receivables 341.4515,390.281.330.231.310.730.0110.5111.7311.399.23
Payables 253.25488.562.221.032.032.870.295.1418.3315.299.90
Total current assets 6,693.5922,360.4716.0825.1613.4518.429.2543.6257.6048.1251.00

Cash Flow Statement

Quarter data
Download APEN cash flow statement Download APEN cash flow statement Download APEN cash flow statement
Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Investing Cash Flow -569.86-468.54-0.49-0.34-0.39-0.54-0.29-2.17-2.147.121.04
Free Cash Flow -1,054.79-3,585.807.57-8.66-13.54-15.72-12.16-15.27-15.46-26.00-26.60
Depreciation & Amortization 176.69165.300.140.190.200.220.479.5210.029.784.68
Net cash flow / Change in cash -1,604.11-14.4124.6211.8517.28-8.39-2.5411.38-6.415.91
Effect of forex changes on cash --------0.100.13-0.11-0.01
Financing Cash Flow 20.534,686.360.0318.870.7721.153.7712.6226.709.7030.51
Dividend payments -------153.98---
Stock-based compensation 587.581,031.800.700.600.841.240.950.380.761.401.49
Investment purchases -----------
Acquisitions and disposals -------0.20---
Capital Expenditure --0.490.340.390.540.292.372.142.880.98
Operating Cash Flow -1,054.79-3,585.808.06-8.31-13.15-15.19-11.87-12.90-13.32-23.12-25.62

Retained Earning Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Retained Earnings (Previous Year) ----40-43-49-66-76-150-177-223
Net Income 3,983-4,602-3-3-7-17-10-41-27-46-27
Stock Dividends -3,9834,602-37-----186--0
Dividend Paid -------154---
Retained Earnings ---40-43-49-66-76-150-177-223-250

PPE Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Gross PPE ---00000776
Annual Depreciation ---0-0-0-1-04-2-4-0
Capital Expenditure --000102231
Net PPE --000007767

Intangible and Goodwill Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Intangible and Goodwill (Previous Year) ---22222504315
New Purchases -----------
Intangible and Goodwill --2222250431513

About


Mr. Todd Newton
Healthcare
Medical Devices
NASDAQ Global Market

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Aus